FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.7050
-0.1250 (-15.06%)
At close: Nov 20, 2026, 4:00 PM EST
0.7220
+0.0170 (2.41%)
After-hours: Nov 20, 2026, 7:45 PM EST
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $4.9 million as of November 20, 2026. It is the 44,689th most valuable company in the world and the 5,868th biggest in the United States. Its market cap has decreased by 74.11% in one year.
Market Cap
4.90M
Enterprise Value
5.01M
1-Year Change
-74.11%
Global Rank
Country Rank
#5,868 United States
Category
ChartMarket Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $4.90M, a decrease of -99.48%. That is a compound annual growth rate of -84.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 4.90M | -67.22% |
| Dec 31, 2025 | 14.96M | -78.68% |
| Dec 31, 2024 | 70.17M | -92.58% |
| Jan 31, 2024 (IPO) | 945.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Enveric Biosciences | 6.36M |
| AEON Biopharma | 6.20M |
| GT Biopharma | 6.19M |
| Cadrenal Therapeutics | 6.14M |
| Longeveron | 6.12M |
| Soligenix | 5.91M |
| Processa Pharmaceuticals | 5.70M |
| Evogene | 5.67M |